The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Treatment of ADHD in children with tics: A randomized controlled trial
Abstract
BACKGROUND: The treatment of children with attention deficit hyperactivity disorder (ADHD) and Tourette syndrome (TS) has been problematic because methylphenidate (MPH)--the most commonly used drug to treat ADHD--has been reported to worsen tics and because clonidine (CLON)--the most commonly prescribed alternative--has unproven efficacy. METHODS: The authors conducted a multicenter, randomized, double-blind clinical trial in which 136 children with ADHD and a chronic tic disorder were randomly administered CLON alone, MPH alone, combined CLON + MPH, or placebo (2 x 2 factorial design). Each subject participated for 16 weeks (weeks 1-4 CLON/placebo dose titration, weeks 5-8 added MPH/placebo dose titration, weeks 9-16 maintenance therapy). RESULTS: Thirty-seven children were administered MPH alone, 34 were administered CLON alone, 33 were administered CLON + MPH, and 32 were administered placebo. For our primary outcome measure of ADHD (Conners Abbreviated Symptom Questionnaire--Teacher), significant improvement occurred for subjects assigned to CLON (p < 0.002) and those assigned to MPH (p < 0.003). Compared with placebo, the greatest benefit occurred with combined CLON + MPH (p < 0.0001). CLON appeared to be most helpful for impulsivity and hyperactivity; MPH appeared to be most helpful for inattention. The proportion of individual subjects reporting a worsening of tics as an adverse effect was no higher in those treated with MPH (20%) than those being administered CLON alone (26%) or placebo (22%). Compared with placebo, measured tic severity lessened in all active treatment groups in the following order: CLON + MPH, CLON alone, MPH alone. Sedation was common with CLON treatment (28% reported moderate or severe sedation), but otherwise the drugs were tolerated well, including absence of any evident cardiac toxicity. CONCLUSIONS: Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics. Prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For clonidine, which is only occasionally used in Europe to treat TD and/or ADHD, but recommended by some authors (especially where TD is the predominant disorder) [116], there exists some evidence that it may reduce tics in frequency and severity, as well as improve ADHD symptoms; but on the other hand, worsening of tics may be seen in about a quarter of cases [3].”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [3]
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Normative data on Revised Conners Parent and Teacher Rating Scales
Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00919127 · Cited by 1,728
Teacher Ratings of DSM-III-R Symptoms for the Disruptive Behavior Disorders
Pelham, W. E., Gnagy, E. M., Greenslade, K. E., & Milich, R. S. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199203000-00006 · Cited by 1,315
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Clonidine Treatment of Gilles de la Tourette's Syndrome
Leckman, J. F. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280040006 · Cited by 334
An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder
Hunt, R. D., Arnsten, A. F. T., & Asbell, M. D. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199501000-00013 · Cited by 308
Effect of Stimulant Medication on Children with Attention Deficit Disorder: A “Review of Reviews”
Swanson, J. M., McBurnett, K., Wigal, T. L., Pfiffner, L. J., Lerner, M., Williams, L., Christian, D. L., Tamm, L., Willcutt, E. G., Crowley, K., et al. (1993) · Exceptional Children · doi:10.1177/001440299306000209 · Cited by 305
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA · doi:10.1001/jama.1982.03320370043028 · Cited by 256
Fisher, P. W., Shaffer, D. R., Piacentini, J. C., Lapkin, J. B., Kafantaris, V., Leonard, H., & Herzog, D. B. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199305000-00026 · Cited by 251
Research works printed but not linked: 7
- Walkup JT Khan S Schuerholz L et al. Phenomenology and natural history of tic-related ADHD and learning disabilities. In: Leckman JF Cohen DJ eds. Tourette’s syndrome: tics obsessions compulsions. New York: Wiley 1999; 63–79.
- Kurlan R Trinidad KS. Treatment of tics. In: Kurlan R ed. The Treatment of Movement Disorders. Philadelphia: JB Lippincott 1995; 365–406.
- Tanner JM. Growth in adolescence 2nd ed. Oxford: Blackwell Scientific 1962.
- Atkins MS Pelham WE Licht MH. The development and validation of objective classroom measures for conduct and attention deficit disorders. In: Prinz R ed. Advances in behavioral assessment of children and families Vol 4. Greenwich CT: JAI Press 1988; 3–33.
- Leckman JF Towbin KE Ort SI Cohen DJ. Clinical assessment of tic disorder severity. In: Cohen DJ Bruun RD Leckman JF eds. Tourette’s syndrome and tic disorders. New York: Wiley 1988: 55–78.
- Scahill L King RA Schultz RT Leckman JF. Selection and use of diagnostic and clinical rating instruments. In: Leckman JF Cohen DJ eds. Tourette’s syndrome tics obsessions compulsions: development psychopathology and clinical care. New York: John Wiley and Sons 1998; 310–324.
- Conners CK, Barkley RA. Rating scales and checklists for psychopharmacologic trials. Psychopharm Bull . 1985; 21: 809–854.
Cited by
Sorted by citations
Pliszka, S. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318054e724 · Cited by 1,765
Attention-deficit hyperactivity disorder
Biederman, J., & Faraone, S. V. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66915-2 · Cited by 1,463
Leckman, J. F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11526-1 · Cited by 696
Attention‐Deficit‐Hyperactivity Disorder: An Update
Dopheide, J. A., & Pliszka, S. R. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.6.656 · Cited by 653
Clinical course of Tourette syndrome
Bloch, M. H., & Leckman, J. F. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.09.002 · Cited by 534
the ESSTS Guidelines Group, Roessner, V., Plessen, K. J., Rothenberger, A., Ludolph, A. G., Rizzo, R., Skov, L., Strand, G., Stern, J. S., Termine, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0163-7 · Cited by 461
Self-citationPLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442
Wolraich, M. L., Wibbelsman, C. J., Brown, T. E., Evans, S. W., Gotlieb, E. M., Knight, J. R., Ross, E. C., Shubiner, H. H., Wender, E. H., & Wilens, T. (2005) · Pediatrics · doi:10.1542/peds.2004-1959 · Cited by 404
Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., Catalá, M. A., Tabarés-Seisdedos, R., & Moher, D. (2017) · PLOS ONE · doi:10.1371/journal.pone.0180355 · Cited by 396
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., Danckaerts, M., Döpfner, M., Faraone, S. V., Rothenberger, A., et al. (2006) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-006-0549-0 · Cited by 375
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Arnsten, A. F. T., Scahill, L. D., & Findling, R. L. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0098 · Cited by 314
Sukhodolsky, D. G., Scahill, L. D., Zhang, H., Peterson, B. S., King, R. A., Lombroso, P. J., Katsovich, L., Findley, D. B., & Leckman, J. F. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200301000-00016 · Cited by 303
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
Attention Deficit–Hyperactivity Disorder
Rappley, M. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmcp032387 · Cited by 296
Bloch, M. H., Panza, K. E., Landeros-Weisenberger, A., & Leckman, J. F. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b26e9f · Cited by 270
Pringsheim, T. M., Holler‐Managan, Y., Okun, M. S., Jankovic, J. J., Piacentini, J. C., Cavanna, A. E., Martino, D., Müller‐Vahl, K., Woods, D. W., Robinson, M., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007467 · Cited by 258
Spencer, T. J., Greenbaum, M., Ginsberg, L. D., & Murphy, W. R. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0152 · Cited by 257
Psychopharmacological Treatment for Very Young Children: Contexts and Guidelines
Gleason, M. M., EGGER, H. L., Emslie, G. J., Greenhill, L. L., Kowatch, R. A., Lieberman, A. F., Luby, J. L., Owens, J. A., Scahill, L. D., Scheeringa, M. S., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181570d9e · Cited by 247
Weisman, H., Qureshi, I. A., Leckman, J. F., Scahill, L. D., & Bloch, M. H. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.09.008 · Cited by 246
Tourette Syndrome and Tic Disorders: A Decade of Progress
Swain, J. E., Scahill, L. D., Lombroso, P. J., King, R. A., & Leckman, J. F. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318068fbcc · Cited by 244
Snider, L. A., Lougee, L., Slattery, M., Grant, P., & Swedo, S. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.035 · Cited by 237
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
Allen, A. J., Kurlan, R. M., Gilbert, D. L., Coffey, B. J., Linder, S. L., Lewis, D. W., Winner, P. K., Dunn, D. W., Dure, L. S., Sallee, F. R., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000188869.58300.a7 · Cited by 225
Tourette syndrome: Evolving concepts
Jankovic, J. J., & Kurlan, R. (2011) · Movement Disorders · doi:10.1002/mds.23618 · Cited by 218
Lin, H., Katsovich, L., Ghebremichael, M. S., Findley, D. B., Grantz, H., Lombroso, P. J., King, R. A., Zhang, H., & Leckman, J. F. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01687.x · Cited by 216
Roessner, V., Eichele, H., Stern, J. S., Skov, L., Rizzo, R., Debes, N. M., Nagy, P., Cavanna, A. E., Termine, C., Ganos, C., et al. (2021) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-021-01899-z · Cited by 222
Hazell, P., & STUART, J. E. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046908.27264.00 · Cited by 200
Neurobiological Substrates of Tourette's Disorder
Leckman, J. F., Bloch, M. H., Smith, M. E., Larabi, D. I., & Hampson, M. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0118 · Cited by 204
Rendleman, R. L., & Walkup, J. T. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00049-4 · Cited by 197
Advances in understanding and treatment of Tourette syndrome
McNaught, K. S. P., & Mink, J. W. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.167 · Cited by 196
Blumer, D. P., Montouris, G., & Davies, K. G. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.08.003 · Cited by 191
Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Pharmacotherapy
Pringsheim, T. M., Doja, A., Gorman, D. A., McKinlay, D., Day, L., Billinghurst, L. L., Carroll, A. M., Dion, Y., Luscombe, S., Steeves, T. D. L., et al. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700302 · Cited by 191
Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder
Croxtall, J. D. (2011) · Pediatric Drugs · doi:10.2165/11208100-000000000-00000 · Cited by 190
Neuromodulation in Tourette syndrome: dopamine and beyond
Buse, J., Schoenefeld, K., Münchau, A., & Roessner, V. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.004 · Cited by 185
Use of clonidine in children with autism spectrum disorders
Ming, X., Gordon, E., Kang, N., & Wagner, G. C. (2008) · Brain and Development · doi:10.1016/j.braindev.2007.12.007 · Cited by 183
Non?stimulant medications in the treatment of ADHD
Banaschewski, T., Roessner, V., Dittmann, R. W., Janardhanan Santosh, P., & Rothenberger, A. (2004) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-004-1010-x · Cited by 183
Practice Parameter on the Use of Psychotropic Medication in Children and Adolescents
Walkup, J. T. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ae0a08 · Cited by 175
A Comprehensive Review of Tic Disorders in Children
Ueda, K., & BLACK, K. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112479 · Cited by 177
European clinical guidelines for Tourette Syndrome and other tic disorders
Roessner, V., Rothenberger, A., Rickards, H. E., & Hoekstra, P. J. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-011-0165-5 · Cited by 176
The Gilles De La Tourette syndrome: the current status
Robertson, M. M. (2012) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2011-300585 · Cited by 167
Pringsheim, T., Hirsch, L., Gardner, D., & Gorman, D. A. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000202 · Cited by 163
Concomitant Psychotropic Medication for Youths
Safer, D. J., ZITO, J. M., & dosReis, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.438 · Cited by 162
Hirota, T., Schwartz, S., & Correll, C. U. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.009 · Cited by 161
Pringsheim, T. M., & Steeves, T. D. L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007990.pub2 · Cited by 160
Pliszka, S. R. (2007) · Neuropsychology Review · doi:10.1007/s11065-006-9017-3 · Cited by 158
Hollis, C. P., Pennant, M. E., Cuenca, J., Glazebrook, C., Kendall, T., Whittington, C. J., Stockton, S., Larsson, L., Bunton, P., Dobson, S., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20040 · Cited by 155
WILENS, T., PELHAM, W., STEIN, M., CONNERS, C. K., ABIKOFF, H., ATKINS, M., AUGUST, G., GREENHILL, L., MCBURNETT, K., PALUMBO, D., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046814.95464.7d · Cited by 148
Gau, S. S., Ni, H., Shang, C., Soong, W., Wu, Y., Lin, L.-Y., & Chiu, Y. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903282733 · Cited by 154
Kollins, S. H., Jain, R., Brams, M. N., Segal, S., Findling, R. L., Wigal, S. B., & Khayrallah, M. A. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1260 · Cited by 146
Jain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.11.005 · Cited by 142
Clonidine for Attention-Deficit/Hyperactivity Disorder: I. Efficacy and Tolerability Outcomes
Palumbo, D. R., Sallee, F. R., Pelham, W. E., Bukstein, O. G., Daviss, W. B., & McDermott, M. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d9af7 · Cited by 140
Abikoff, H., McGough, J. J., Vitiello, B., McCracken, J. T., Davies, M., Walkup, J. T., Riddle, M. A., Oatis, M. D., Greenhill, L. L., Skrobala, A. M., et al. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000155320.52322.37 · Cited by 140
Evidence-Based Treatments in Child and Adolescent Psychiatry: An Inventory
McClellan, J., & WERRY, J. S. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200312000-00005 · Cited by 137
Treatment of Tics and Tourette Syndrome
Singer, H. S. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0095-4 · Cited by 133
Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
Quezada, J., & Coffman, K. A. (2018) · CNS Drugs · doi:10.1007/s40263-017-0486-0 · Cited by 131
Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics
Martino, D., Ganos, C., & Pringsheim, T. M. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.006 · Cited by 133
Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder
Pliszka, S. R. (2003) · Pediatric Drugs · doi:10.2165/00148581-200305110-00003 · Cited by 129
Current controversies on the role of behavior therapy in Tourette syndrome
Scahill, L. D., Woods, D. W., Himle, M. B., Peterson, A. L., Wilhelm, S., Piacentini, J. C., McNaught, K. S. P., Walkup, J. T., & Mink, J. W. (2013) · Movement Disorders · doi:10.1002/mds.25488 · Cited by 124
Gilles de la Tourette syndrome: the complexities of phenotype and treatment
Robertson, M. M. (2011) · British Journal of Hospital Medicine · doi:10.12968/hmed.2011.72.2.100 · Cited by 123
Singer, H. S. (2019) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000752 · Cited by 126
Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments
Billnitzer, A., & Jankovic, J. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00914-6 · Cited by 122
Whittington, C. J., Pennant, M. E., Kendall, T., Glazebrook, C., Trayner, P., Groom, M. J., Hedderly, T. J., Heyman, I., Jackson, G. M., Jackson, S. R., et al. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12556 · Cited by 121
Wilens, T. E., Bukstein, O. G., Brams, M. N., Cutler, A. J., Childress, A. C., Rugino, T. A., Lyne, A., Grannis, K., & Youcha, S. H. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.10.012 · Cited by 118
Neuropsychiatric consequences of cardiovascular medications
Huffman, J. C., & Stern, T. A. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.1/jchuffman · Cited by 116
Osland, S., Steeves, T. D. L., & Pringsheim, T. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007990.pub3 · Cited by 125
Pappadopulos, E., Jensen, P. S., Chait, A. R., Arnold, L. E., Swanson, J. M., Greenhill, L. L., Hechtman, L., Chuang, S., Wells, K. C., Pelham, W., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23ed · Cited by 112
Non-Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder
Pliszka, S. R. (2003) · CNS Spectrums · doi:10.1017/s1092852900018460 · Cited by 111
Shprecher, D., & Kurlan, R. (2008) · Movement Disorders · doi:10.1002/mds.22378 · Cited by 110
Tourette Syndrome in Children: An Updated Review
Du, J., Chiu, T.-F., Lee, K.-M., Wu, H.-L., Yang, Y.-C., Hsu, S.-Y., Sun, C.-S., Hwang, B., & Leckman, J. F. (2010) · Pediatrics & Neonatology · doi:10.1016/s1875-9572(10)60050-2 · Cited by 106
Tic reduction with pergolide in a randomized controlled trial in children
Gilbert, D. L., Dure, L. S., Sethuraman, G., Raab, D., Lane, J. B., & Sallee, F. R. (2003) · Neurology · doi:10.1212/01.wnl.0000044058.64647.7e · Cited by 106
Cohen, S. C., Mulqueen, J. M., Ferracioli-Oda, E., Stuckelman, Z. D., Coughlin, C. G., Leckman, J. F., & Bloch, M. H. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.06.011 · Cited by 105
Kurlan, R. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1007805 · Cited by 105
Treatment of Children and Adolescents With Tics and Tourette Syndrome
Gilbert, D. L. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210080401 · Cited by 104
Clinical Characteristics of Children and Adolescents with a Primary Tic Disorder
Specht, M. W., Woods, D. W., Piacentini, J. C., Scahill, L. D., Wilhelm, S., Peterson, A. L., Chang, S. W., Kepley, H. O., Deckersbach, T., Flessner, C. A., et al. (2011) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-010-9223-z · Cited by 102
Clonidine for Attention-Deficit/Hyperactivity Disorder: II. ECG Changes and Adverse Events Analysis
Daviss, W. B., Patel, N. C., Robb, A. S., McDermott, M., Bukstein, O. G., Pelham, W. E., Palumbo, D. R., HARRIS, P., & Sallee, F. R. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d9ae4 · Cited by 101
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Rasmussen, P. D., Huus, C.-M. L., Zwi, M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub3 · Cited by 118
van de Loo-Neus, G. H. H., Rommelse, N., & Buitelaar, J. K. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.03.008 · Cited by 98
Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome
Spencer, T. J., Sallee, F. R., Gilbert, D. L., Dunn, D. W., McCracken, J. T., Coffey, B. J., Budman, C. L., Ricardi, R. K., Leonard, H. L., Allen, A. J., et al. (2008) · Journal of Attention Disorders · doi:10.1177/1087054707306109 · Cited by 98
Erenberg, G. (2005) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2005.12.003 · Cited by 98
Co-occurring Psychiatric Disorders in Children and Adolescents With Tourette Syndrome
Gaze, C. M., Kepley, H. O., & Walkup, J. T. (2006) · Journal of Child Neurology · doi:10.1177/08830738060210081301 · Cited by 97
Clinical features of Tourette syndrome and tic disorders
Leckman, J. F., King, R. A., & Bloch, M. H. (2014) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2014.03.004 · Cited by 98
Double-Blind, Crossover Study of Clonidine and Levetiracetam in Tourette Syndrome
Hedderick, E. F., Morris, C. M., & Singer, H. S. (2009) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2008.12.014 · Cited by 95
Gorman, D. A., Gardner, D. M., Murphy, A. L., Feldman, M., Bélanger, S. A., Steele, M. M., Boylan, K., Cochrane-Brink, K., Goldade, R., Soper, P. R., et al. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000204 · Cited by 99
Recent advances in Tourette syndrome
Bloch, M., State, M., & Pittenger, C. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328344648c · Cited by 91
Geller, D. A., Homayoun, S., & Johnson, G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678538 · Cited by 89
Waxmonsky, J. G. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200310000-00006 · Cited by 89
Cannabinoids for Tourette's Syndrome
Curtis, A., Clarke, C. E., & Rickards, H. E. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006565.pub2 · Cited by 88
Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder
Wilens, T. E. (2003) · Drugs · doi:10.2165/00003495-200363220-00002 · Cited by 86
Pharmacological management of tics in patients with TS
Sandor, P. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(03)00060-6 · Cited by 85
Dopamine transporter genotype influences the physiological response to medication in ADHD
Gilbert, D. L. (2006) · Brain · doi:10.1093/brain/awl147 · Cited by 85
Efron, D., & Dale, R. C. (2018) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.14165 · Cited by 79
Understanding disability in Tourette syndrome
Pringsheim, T. M., Lang, A. E., Kurlan, R., Pearce, M., & Sandor, P. (2009) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.03168.x · Cited by 79
Enlargement of Thalamic Nuclei in Tourette Syndrome
Miller, A. M., Bansal, R., Hao, X., Sanchez‐Peña, J., Sobel, L. J., Liu, J., Xu, D., Hongtu Zhu, B., Chakravarty, M. M., Durkin, K., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.102 · Cited by 78
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents
Childress, A. C., & Berry, S. A. (2012) · Drugs · doi:10.2165/11599580-000000000-00000 · Cited by 77
Review of Safety Assessment Methods Used in Pediatric Psychopharmacology
Greenhill, L. L., Shockey, E. M., Davies, M., Fisher, P. W., Fried, J. E., Capasso, L., ROSENGARTEN, J., Vitiello, B., Riddle, M. A., VARIPATIS, E., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046841.56865.37 · Cited by 77
Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options
Rizzo, R., Gulisano, M., Calì, P. V., & Curatolo, P. (2013) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2013.01.005 · Cited by 76
Immediate-Release Methylphenidate for ADHD in Children With Comorbid Chronic Multiple Tic Disorder
Gadow, K. D., Sverd, J., Nolan, E. E., Sprafkin, J. N., & Schneider, J. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31805c0860 · Cited by 75
Gilles de la Tourette’s syndrome and its impact in the UK
Stern, J. S., Burza, S., & Robertson, M. M. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.023614 · Cited by 73
Efron, D., Hiscock, H., Sewell, J. R., Cranswick, N., Vance, A. L. A., Tyl, Y., & Luk, E. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.372 · Cited by 73
Metadata
- Authors
- The Tourette’s Syndrome Study Group
- Corresponding author
- The Tourette’s Syndrome Study Group
- Venue
- Neurology
- Published
- 2002-02-26
- Volume
- 58
- Issue
- 4
- Pages
- 527-536
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2266471137
- Cited by
- 504
- References
- 40
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 18 · 2023: 15 · 2022: 13 · 2021: 15 · 2020: 14 · 2019: 18 · 2018: 13 · 2017: 14 · 2016: 18 · 2015: 19 · 2014: 17 · 2013: 11 · 2012: 37
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns033654-04)
- National Institute of Neurological Disorders and Stroke (1R01NS33654)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, Tourette syndrome, tic disorders, methylphenidate, clonidine, combination therapy, impulsivity, hyperactivity, inattention, sedation
- MeSH terms
- Adolescent, Adrenergic alpha-Agonists, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Clonidine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Methylphenidate, Surveys and Questionnaires, Tic Disorders, Confidence Intervals, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review